和元生物：2025年前三季度净利润约-1.62亿元

Group 1 - The core viewpoint of the article highlights the financial performance of He Yuan Bio, indicating a decline in revenue and a significant net loss for the third quarter of 2025 [1] - He Yuan Bio reported revenue of approximately 180 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 1.91% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 162 million yuan, with basic earnings per share reflecting a loss of 0.254 yuan [1] Group 2 - As of the report, He Yuan Bio has a market capitalization of 4.9 billion yuan [2]